Issue 18.3
CASE STUDY: Recipe for success in freeze-drying a cytotoxic product
Telstar reveals its solution to developing a freeze-drying recipe for a cytotoxic product in a solution of water and tert-butyl alcohol as a solvent, in this case study. Read more
Contamination risk? Examining the potential risk of single-use plastic bioprocess bags
Dujuan Lu, PhD (technical client manager/global lead, SGS Life Science Services) and Kate Comstock (senior marketing specialist, Thermo Fisher Scientific) assess whether or not contaminants leach out from single-use bioprocess bags Read more
At the heart of it… why quaternary diaphragm pumps are ideal for biopharma manufacturing
In this article, Glenn Hiroyasu, Quattroflow Fluid Systems, examines the challenges of flow rate and pressure in chromatography, virus filtration, TFF and inline blending processes and illustrates why the quaternary diaphragm pump is ideal Read more
CASE STUDY: Working the problem — how to resolve sticking issues in tablet production
In this case study, a prediction model is used in conjunction with an examination of a tablet profile to resolve sticking issues. Read more
A fresh perspective on oral solid dosage forms
When it comes to oral solid dosage (OSD) forms, continuous manufacturing is in high demand. But there is more than one way to look at things, as Fritz-Martin Scholz, product manager at Bosch Packaging Technology explains. Read more
Getting our fill… looking at the latest developments in coatings and capsules
Iñaki Bueno, formulation and manufacturing manager at Idifarma tells us more about the ins and outs, challenges, advantages and latest developments in coatings and capsules. Read more
What the future holds for pharma packaging
The introduction of new technologies over the last decade has paved the way for pharmaceutical packaging companies to explore new and innovative solutions, improve their operations and drive efficiencies across the supply chain. Here, Dexter Tjoa, di Read more
A long way to go… what are the next steps to protect public health from falsified medicines?
Five years on from the adoption of the EU falsified medicines directive (2011/62/EU) and the challenge continues. Here, Vincenzo Salvatore, BonelliErede (Milan), looks at the reasoning behind the directive and potential next steps Read more
Are you ready for serialisation? Three experts give their perspectives
After a preview of TraceLink’s second annual Global Drug Supply, Safety and Traceability survey has revealed disparity in terms of readiness for the FMD between pharma companies and CMOs, three experts give us their perspectives on serialisation Read more
For all practical purposes — key challenges and practical questions to achieving FMD compliance
As the falsified medicines directive is set to come into full force early next year, Christian Taylor, serialisation business consultant, Zetes, looks at the key challenges and practical questions relating to achieving compliance in more detail. Read more
Weighing it up… why aggregation is worth the consideration
In this article, Marco Baietti, commercial director at SEA Vision, weighs up the advantages of implementing aggregation, what the future holds and the current levels of adoption within the industry. Read more
Reducing the odds — how to prepare for the impact of big data
In this guide, Manuel Duval, PhD, from Scientist.com looks at how pharma and biopharma companies can best prepare for the impact of big data in healthcare. Read more
Disrupt or be disrupted? Why blockchain will change your world
Here, Scott Allison, president, Life Sciences & Healthcare, DHL, and Keith Turner, CIO Chief Development Office, Life Sciences & Healthcare, Service Logistics, DHL Supply Chain, look at the importance of blockchain in logistics. Read more
Bridging the gap between clinical development and patient access with real-world evidence
Here, Dr Chitra Lele, chief scientific officer at Sciformix Corporation discusses the real-world evidence's (RWE’s) continuum and how it could bridge the gap between clinical development and patient access. Read more
Achieving the desired end goal: Best approaches to achieving Policy 0070 compliance
Pooja Phogat, regulation and compliance expert at Kinapse, advises on the best approaches to balancing the risk of patient re-identification with the need for greater data utility. Read more
Getting a handle on GDPR — what should you be aware of to be compliant?
As the General Data Protection Regulation (GDPR) take effect this month, Mark Stevens, managing director, Formpipe Life Science, looks at the key differences companies should be aware of and how they can attain compliance. Read more
Looking at the bigger picture in clinical packaging
Operating clinical studies with a silo mentality with undoubtedly yield poor results. With various risks associated at each stage Adrian Collins, Almac Clinical Services, explores the hidden challenges of clinical packaging and how to overcome them… Read more
Tech Talk no.3: Show me the money in mHealth apps
In the latest instalment of Tech Talk, Novarum founder and BBI Group head of mobile, Dr Neil Polwart discusses how best to monetise your mHealth app. Read more
Reducing risk in pharmaceutical production with sterile transfer ports
In this article, Anneke Evers, senior director Sales & Market Support DPTE Sterile Transfer, Getinge, discusses sterile transfer systems, industry standards and what the next steps to evolve these systems need to be. Read more
Never too big to fail… and other lessons pharma can learn from Carillion
Here, Mark Tempest, VWV partner in the Insolvency and Restructuring and Pharmaceuticals and Life Sciences teams, looks at the construction giant’s case in more detail and what pharma and life sciences should consider in order to protect themselves. Read more
